Hospital admissions due to suicide attempts during the COVID-19 pandemic, a 3-year longitudinal study.

Autor: Rodriguez-Jimenez R; Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain; Instituto de Investigación 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain; CIBERSAM-ISCIII (Biomedical Research Networking Centre in Mental Health), Spain., García-Fernández L; CIBERSAM-ISCIII (Biomedical Research Networking Centre in Mental Health), Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, San Juan, Alicante, Spain; Servicio de Psiquiatría, Hospital Universitario de San Juan, San Juan, Alicante, Spain. Electronic address: lorena.garciaf@umh.es., Baón-Pérez B; Oficina Regional de Coordinación de Salud Mental y Adicciones, Servicio Madrileño de Salud, Madrid, Spain., Ansede-Cascudo JC; Oficina Regional de Coordinación de Salud Mental y Adicciones, Servicio Madrileño de Salud, Madrid, Spain., Arroba CM; Scientific Support Unit, Research Institute (imas12), University Hospital '12 de Octubre', Madrid, Spain., Sendra-Gutierrez JM; Oficina Regional de Coordinación de Salud Mental y Adicciones, Servicio Madrileño de Salud, Madrid, Spain., Romero-Ferreiro V; Instituto de Investigación 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain; CIBERSAM-ISCIII (Biomedical Research Networking Centre in Mental Health), Spain; Departmento de Psicología, Universidad Europea de Madrid, Madrid, Spain., Sánchez-Cabezudo Á; Instituto de Investigación 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain., Alvarez-Mon MA; Departmento de Medicina y Especialidades Médicas, Universidad de Alcala, Alcala de Henares, Madrid 28801, Spain; Instituto Ramón y Cajal de INvestigación Sanitaria (IRYCIS), Madrid 28034, Spain; Departmento de Psiquiatría y Salud Mental, Hospital Universitario Infanta Leonor, Madrid, Spain., Navío-Acosta M; Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain; Instituto de Investigación 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain; CIBERSAM-ISCIII (Biomedical Research Networking Centre in Mental Health), Spain; Oficina Regional de Coordinación de Salud Mental y Adicciones, Servicio Madrileño de Salud, Madrid, Spain.
Jazyk: angličtina
Zdroj: Psychiatry research [Psychiatry Res] 2023 Sep; Vol. 327, pp. 115346. Date of Electronic Publication: 2023 Jul 17.
DOI: 10.1016/j.psychres.2023.115346
Abstrakt: The appearance of the SARS CoV-2 virus and the associated COVID-19 pandemic has been associated with the onset of mental disorders in healthy people and the worsening in those with pre-existing mental conditions. One of the areas that has raised the greatest concern is that of suicidality. Most of the published studies have been carried out cross-sectional or with small samples, without stratifying by age and gender. Thus, the aim of this longitudinal research is to study, in a large population sample of around 6,700,000 inhabitants belonging to the entire region of Madrid (Spain), the admissions in psychiatric hospitalization units due to suicidal attempts along 2019, 2020 and 2021. No clear increase in the number of admissions due to suicidality in the total population have been found. In addition, a higher prevalence in admissions among women is verified. Moreover, stratifying by age and gender, a striking and significant increase in hospital admissions due to suicidality has been observed in the group up to 17 years old, from September 2020 until the end of the study. These results highlight the special vulnerability of children and adolescents, specifically girls, and the need for preventive measures in the face of future pandemics.
Competing Interests: Declaration of Competing Interest Dr. R. Rodriguez-Jimenez has been a consultant for, spoken in activities of, or received grants from: Instituto de Salud Carlos III, Fondo de Investigación Sanitaria (FIS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid Regional Government (S2010/ BMD-2422 AGES; S2017/BMD-3740), JanssenCilag, Lundbeck, Otsuka, Pfizer, Ferrer, Juste, Takeda, Exeltis, Casen-Recordati, Angelini, Rovi. All other authors have no conflict of interest.
(Copyright © 2023. Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: